These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27940058)

  • 1. Eicosanoid receptors: Targets for the treatment of disrupted intestinal epithelial homeostasis.
    Moreno JJ
    Eur J Pharmacol; 2017 Feb; 796():7-19. PubMed ID: 27940058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting gut barrier dysfunction with phytotherapies: Effective strategy against chronic diseases.
    Dey P
    Pharmacol Res; 2020 Nov; 161():105135. PubMed ID: 32814166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation.
    Auteri M; Zizzo MG; Serio R
    Pharmacol Res; 2015 Mar; 93():11-21. PubMed ID: 25526825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid droplets in activated mast cells - a significant source of triglyceride-derived arachidonic acid for eicosanoid production.
    Dichlberger A; Schlager S; Kovanen PT; Schneider WJ
    Eur J Pharmacol; 2016 Aug; 785():59-69. PubMed ID: 26164793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo α-hydroxylation of a 2-alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid in monkeys.
    Chourey S; Ye Q; Reddy CN; Cossette C; Gravel S; Zeller M; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
    Biochem Pharmacol; 2017 Aug; 138():107-118. PubMed ID: 28476332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxyflavone and structural analogues differentially activate pregnane X receptor: Implication for inflammatory bowel disease.
    Lau AJ; Chang TK
    Pharmacol Res; 2015 Oct; 100():64-72. PubMed ID: 26238175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
    Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
    J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.
    Sałaga M; Sobczak M; Fichna J
    Eur J Pharm Sci; 2014 Feb; 52():173-9. PubMed ID: 24275607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxyeicosatetraenoic acid and leukotriene D4 increase intestinal epithelial paracellular permeability.
    Rodríguez-Lagunas MJ; Storniolo CE; Ferrer R; Moreno JJ
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1318-26. PubMed ID: 23583294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid and mineral receptors as drug targets for gastrointestinal disorders.
    Pongkorpsakol P; Moonwiriyakit A; Muanprasat C
    Future Med Chem; 2017 Mar; 9(3):315-334. PubMed ID: 28207290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modifications as therapeutic targets for intestinal disorders.
    Choo J; Heo G; Pothoulakis C; Im E
    Pharmacol Res; 2021 Mar; 165():105412. PubMed ID: 33412276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones.
    During A; Larondelle Y
    Biochem Pharmacol; 2013 Dec; 86(12):1739-46. PubMed ID: 24134915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arachidonic acid metabolites on the control of non-differentiated intestinal epithelial cell growth.
    Cabral M; Martín-Venegas R; Moreno JJ
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1620-8. PubMed ID: 23685077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation.
    Verstrepen L; Beyaert R
    Biochem Pharmacol; 2014 Dec; 92(4):519-29. PubMed ID: 25449604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faster, better, stronger: towards new antidepressant therapeutic strategies.
    O'Leary OF; Dinan TG; Cryan JF
    Eur J Pharmacol; 2015 Apr; 753():32-50. PubMed ID: 25092200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.
    Cathcart MC; Lysaght J; Pidgeon GP
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):363-85. PubMed ID: 22134655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line.
    Cabral M; Martín-Venegas R; Moreno JJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G664-71. PubMed ID: 25035111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine receptors as potential targets in melanoma.
    Montinaro A; Iannone R; Pinto A; Morello S
    Pharmacol Res; 2013 Oct; 76():34-40. PubMed ID: 23856527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage.
    Catanzaro D; Rancan S; Orso G; Dall'Acqua S; Brun P; Giron MC; Carrara M; Castagliuolo I; Ragazzi E; Caparrotta L; Montopoli M
    PLoS One; 2015; 10(5):e0125375. PubMed ID: 25955295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.